Valuation : Navamedic ASA

Market Cap 332M 35.76M 30.81M 29.18M 26.45M 49.62M 3.42B 49.87M 347M 133M 1.74B 134M 131M 5.49B P/E 2026 *
-51.6x
P/E 2027 * 44.3x
Enterprise Value 452M 48.63M 41.9M 39.68M 35.96M 67.47M 4.65B 67.81M 471M 181M 2.36B 183M 179M 7.47B EV / Sales 2026 *
0.79x
EV / Sales 2027 * 0.71x
Free-Float
30.82%
Yield 2026 *
-
Yield 2027 * -
1 day+1.84%
Current month-2.12%
1 month-17.56%
3 months-17.31%
6 months-30.58%
Current year-41.81%
1 week 13.25
Extreme 13.25
13.95
1 month 13.25
Extreme 13.25
17.75
Current year 13.25
Extreme 13.25
24.5
1 year 13.25
Extreme 13.25
26.5
3 years 13.25
Extreme 13.25
43.9
5 years 13.25
Extreme 13.25
43.9
10 years 8.5
Extreme 8.5
43.9
Manager TitleAgeSince
Chief Executive Officer 55 17/06/2026
Director of Finance/CFO - 31/12/2025
Compliance Officer - -
Director TitleAgeSince
Director/Board Member 54 31/05/2022
Director/Board Member - 31/05/2023
Director/Board Member 60 31/05/2024
Date Insider Type Main position Quantity % Market Cap. Importance
19/12/24 Buy

Chief Operating Officer

10,267 0.0581%
09/09/24 Exercice

Chief Executive Officer

80,000 0.4589%
09/09/24 Exercice

Chief Operating Officer

75,000 0.4302%
Change 5-day change 1-year change 3-year change Capi.($)
+1.84%0.00%-37.05%-61.95% 35.76M
-0.65%-2.93%+47.70%+86.17% 994B
-0.29%-3.51%+49.15%+62.35% 640B
+0.83%+0.26%+17.76%+72.25% 454B
-0.38%-3.59%+30.13%+35.17% 337B
-0.09%-13.54%+13.34%+24.95% 261B
-0.43%-2.48%-0.73%+9.58% 246B
-1.34%-13.70%+36.53%+44.96% 204B
-3.44%-7.51%-20.63%-59.44% 190B
-0.75%-4.82%+25.46%+87.14% 178B
Average -0.47%-5.18%+16.17%+30.12% 350.48B
Weighted average by Cap. -0.51%-4.42%+30.96%+54.94%

Financials

2026 *2027 *
Net sales 570M 61.36M 52.87M 50.06M 45.37M 85.12M 5.86B 85.55M 595M 229M 2.98B 230M 225M 9.42B 604M 65.03M 56.03M 53.06M 48.09M 90.22M 6.21B 90.68M 630M 242M 3.16B 244M 239M 9.99B
Net income -6.5M -699K -603K -571K -517K -970K -66.83M -975K -6.78M -2.61M -34M -2.63M -2.57M -107M 7.7M 829K 714K 676K 613K 1.15M 79.19M 1.16M 8.03M 3.09M 40.29M 3.11M 3.04M 127M
Net Debt 120M 12.87M 11.09M 10.5M 9.52M 17.85M 1.23B 17.94M 125M 47.94M 625M 48.33M 47.27M 1.98B 96.9M 10.43M 8.99M 8.51M 7.72M 14.47M 997M 14.55M 101M 38.88M 507M 39.19M 38.33M 1.6B
Logo Navamedic ASA
Navamedic ASA is a Norway-based pharmaceutical company. It is a supplier of products delivered to hospitals and pharmacies. Navamedic’s product portfolio consists of prescription and Over The Counter (OTC) pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. The Company’s offering is divided into four product areas: Consumer Health, Specialty Pharma, Medical Nutrition and Branded Generics. The Company has one business segment which is the Pharma division. Navamedic ASA is present in all Nordic countries, the Baltics and Benelux. The Company has two subsidiaries, Navamedic AB, through which the Company distributes more than 40 products and a Norway-based Novicus Pharma AS.
Employees
38
Date Price Change Volume
11/09/26 NOK 13.85 +1.84% 47,585
10/09/26 NOK 13.60 +0.37% 59,681
09/09/26 NOK 13.55 +0.37% 58,343
08/09/26 NOK 13.50 -1.46% 62,787
07/09/26 NOK 13.70 -1.08% 67,116
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
13.85NOK
Average target price
21.00NOK
Spread / Average Target
+51.62%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NAVA Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!